Starget Pharma
Ramat Hasharon
About Starget Pharma
Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $33.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2026)
- Website: stargetpharma.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/starget-pharma-62216 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.